Literature DB >> 25540037

Natural history of chronic hepatitis B virus infection.

Katrin Busch1, Robert Thimme.   

Abstract

Hepatitis B virus infection represents a major global health problem. Currently, there are more than 240 million chronically infected people worldwide. The development of chronic hepatitis B virus-mediated liver disease may lead to liver fibrosis, cirrhosis and eventually hepatocellular carcinoma. Recently, the discovery of the viral entry receptor sodium taurocholate cotransporting polypeptide has facilitated new approaches for a better understanding of viral physiopathology. Hopefully, these novel insights may give rise to the development of more effective antiviral therapy concepts during the next years. In this review, we will discuss the natural history of hepatitis B virus infection including the viral biology, the clinical course of infection and the role of the immune response.

Entities:  

Mesh:

Year:  2014        PMID: 25540037     DOI: 10.1007/s00430-014-0369-7

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  85 in total

1.  Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity.

Authors:  Philipp A Lang; Karl S Lang; Haifeng C Xu; Melanie Grusdat; Ian A Parish; Mike Recher; Alisha R Elford; Salim Dhanji; Namir Shaabani; Charles W Tran; Dilan Dissanayake; Ramtin Rahbar; Magar Ghazarian; Anne Brüstle; Jason Fine; Peter Chen; Casey T Weaver; Christoph Klose; Andreas Diefenbach; Dieter Häussinger; James R Carlyle; Susan M Kaech; Tak W Mak; Pamela S Ohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-13       Impact factor: 11.205

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation.

Authors:  Bertram Bengsch; Bianca Martin; Robert Thimme
Journal:  J Hepatol       Date:  2014-07-10       Impact factor: 25.083

4.  Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.

Authors:  B J McMahon; P Holck; L Bulkow; M Snowball
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

5.  Expression of the precore region of an avian hepatitis B virus is not required for viral replication.

Authors:  C Chang; G Enders; R Sprengel; N Peters; H E Varmus; D Ganem
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion.

Authors:  Chia-Ming Chu; Chau-Ting Yeh; Ching-Song Lee; I-Shyan Sheen; Yun-Fan Liaw
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

7.  Genomic fossils calibrate the long-term evolution of hepadnaviruses.

Authors:  Clément Gilbert; Cédric Feschotte
Journal:  PLoS Biol       Date:  2010-09-28       Impact factor: 8.029

8.  Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.

Authors:  Mauro Manno; Calogero Cammà; Filippo Schepis; Fabio Bassi; Roberta Gelmini; Francesco Giannini; Francesca Miselli; Antonella Grottola; Ilva Ferretti; Chiara Vecchi; Marisa De Palma; Erica Villa
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

9.  Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.

Authors:  Andreas Schulze; Philippe Gripon; Stephan Urban
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

10.  Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection.

Authors:  Abhishek Das; Matthew Hoare; Nathan Davies; A Ross Lopes; Claire Dunn; Patrick T F Kennedy; Graeme Alexander; Helene Finney; Alistair Lawson; Fiona J Plunkett; Antonio Bertoletti; Arne N Akbar; Mala K Maini
Journal:  J Exp Med       Date:  2008-08-11       Impact factor: 14.307

View more
  20 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication.

Authors:  Ahmed Diab; Adrien Foca; Floriane Fusil; Thomas Lahlali; Pascal Jalaguier; Fouzia Amirache; Lia N'Guyen; Nathalie Isorce; François-Loïc Cosset; Fabien Zoulim; Ourania Andrisani; David Durantel
Journal:  Hepatology       Date:  2017-11-06       Impact factor: 17.425

Review 3.  Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.

Authors:  Pei-Pei Song; Ju-Feng Xia; Yoshinori Inagaki; Kiyoshi Hasegawa; Yoshihiro Sakamoto; Norihiro Kokudo; Wei Tang
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Interaction between Toll-Like Receptor 9-CpG Oligodeoxynucleotides and Hepatitis B Virus Virions Leads to Entry Inhibition in Hepatocytes and Reduction of Alpha Interferon Production by Plasmacytoid Dendritic Cells.

Authors:  Ludovic Aillot; Marc Bonnin; Malika Ait-Goughoulte; Nathalie Bendriss-Vermare; Sarah Maadadi; Laura Dimier; Miroslava Subic; Caroline Scholtes; Isabel Najera; Fabien Zoulim; Julie Lucifora; David Durantel
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

5.  Inadequate activation of the HBsAg-specific Th cells by APCs leads to hyporesponsiveness to HBsAg vaccine in B10.S mice.

Authors:  Xiaofei Li; Jing Xu; Zhihui Lv; Jing Wang; Shuhui Sun; Wei Zhu; Bin Wang; Rui He; Di Qu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.

Authors:  Michiko Hyakumura; Renae Walsh; Morten Thaysen-Andersen; Natalie J Kingston; Mylinh La; Louis Lu; George Lovrecz; Nicolle H Packer; Stephen Locarnini; Hans J Netter
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

7.  Correlation between polymorphisms in toll-like receptor genes and the activity of hepatitis B virus among treatment-naïve patients: a case-control study in a Han Chinese population.

Authors:  Yong Lin; Zheng-Xiang Gao; Xu Shen; Mei-Jun Chen; Yan-Ting Li; Shu-Lian Li; Hui-Ling Lin; Qi-Feng Zhao; Fan Liu; Jian-Jun Niu
Journal:  BMC Infect Dis       Date:  2018-01-10       Impact factor: 3.090

8.  Evaluation of eLIFT for Non-invasive Assessment of Liver fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Virus Infection.

Authors:  Qiang Li; Chuan Lu; Weixia Li; Yuxian Huang; Liang Chen
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

Review 9.  Hepatitis B Virus Infection in Tanzania: Current Status and Challenges.

Authors:  Semvua B Kilonzo; Daniel W Gunda; Bonaventura C T Mpondo; Fatma A Bakshi; Hyasinta Jaka
Journal:  J Trop Med       Date:  2018-01-30

Review 10.  Aspects on the history of transmission and favor of distribution of viruses by iatrogenic action: perhaps an example of a paradigm of the worldwide spread of HIV.

Authors:  Lutz G Gürtler; Josef Eberle
Journal:  Med Microbiol Immunol       Date:  2017-04-22       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.